Genetic Engineering & Biotechnology News (GEN)

Genetic Engineering & Biotechnology News (GEN) is a news platform that covers the latest advancements in gene and cell therapy. The site focuses on topics such as translational medicine, infectious diseases, and protein folding. The articles published often discuss new research findings and breakthroughs in these fields. While there is no explicit mention of any conflicts of interest or biases, it's worth noting that the site's editorial team is present at conferences and has interviews with key figures in the industry. This may provide them with access to information that other outlets might not have.

99%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • The vaccine uses live, modified version of a virus and relies on small RNA molecules instead of traditional immune response or immune active proteins.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • New Study Uncovers Link Between Resilience, Brain Function, and Healthy Gut Microbiomes

    New Study Uncovers Link Between Resilience, Brain Function, and Healthy Gut Microbiomes

    Broke On: Friday, 21 June 2024 A new study published in Nature Mental Health reveals that resilient individuals exhibit improved brain function and healthier gut microbiomes, with reduced inflammation and stronger gut barriers compared to less resilient people. Led by Arpana Gupta from UCLA's Goodman-Luskin Microbiome Center, this research is the first of its kind to explore the connection between resilience, brain function, and gut health.
  • New Autoantibody Signature Identified in 10% of Multiple Sclerosis Patients Years Before Symptoms Appear: Implications for Earlier Detection and Treatment

    New Autoantibody Signature Identified in 10% of Multiple Sclerosis Patients Years Before Symptoms Appear: Implications for Earlier Detection and Treatment

    Broke On: Monday, 01 April 2024 Researchers from UC San Francisco and the Department of Defense Serum Repository identify unique autoantibody signature in 10% of multiple sclerosis (MS) patients years before symptoms appear, paving way for earlier diagnosis and treatment. Discovery could lead to a simple blood test for early detection, allowing for timely intervention with more effective therapies.
  • New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

    New RNA-Based Vaccine Strategies Offer Broad Protection Against Viruses like Influenza and SARS-CoV-2

    Broke On: Monday, 15 April 2024 Scientists at the University of California and Georgia Tech have developed RNA-based vaccine strategies that target a common part of viral genomes, potentially offering broad protection against various strains including influenza and SARS-CoV-2. These vaccines are safer for vulnerable populations, as they don't rely on traditional immune responses or active proteins. Promising results in mice experiments indicate the need for further human testing.

  • Breakthrough in Protein Folding Understanding Opens New Therapeutic Avenues

    Broke On: Monday, 04 December 2023 Researchers at the University of Massachusetts Amherst have deciphered a carbohydrate-based code that is critical for protein folding. The study focused on a family of proteins known as serpins, which are implicated in various diseases. The enzyme UGGT tags misfolded proteins with sugars in specific positions, allowing chaperones to determine where the folding process went wrong and how to fix it.